Filing Details

Accession Number:
0000899243-23-003144
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-01 17:10:24
Reporting Period:
2023-01-30
Accepted Time:
2023-02-01 17:10:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
831547 Spectrum Pharmaceuticals Inc SPPI Pharmaceutical Preparations (2834) 930979187
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726378 J Thomas Riga 2 Atlantic Avenue, 6Th Floor
Boston MA 02110
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2023-01-30 69,389 $0.54 2,008,022 No 4 S Direct
Common Stock, $0.001 Par Value Disposition 2023-01-31 107,424 $0.66 1,900,598 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 14,139 Indirect By 401(k) plan
Footnotes
  1. All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
  2. This transaction was executed in multiple trades at prices that when rounded to the nearest cent were equal to $0.66. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.